Insmed Incorporated
INSM
$132.17
$3.853.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 398.11M | 381.03M | 363.71M | 342.96M | 328.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 398.11M | 381.03M | 363.71M | 342.96M | 328.61M |
| Cost of Revenue | 96.67M | 89.56M | 85.74M | 78.03M | 73.57M |
| Gross Profit | 301.43M | 291.47M | 277.97M | 264.92M | 255.04M |
| SG&A Expenses | 563.75M | 515.56M | 461.12M | 408.13M | 379.83M |
| Depreciation & Amortization | 5.05M | 5.05M | 5.05M | 5.05M | 5.05M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.33B | 1.24B | 1.15B | 1.05B | 972.46M |
| Operating Income | -927.68M | -859.01M | -786.57M | -703.93M | -643.85M |
| Income Before Tax | -1.03B | -1.01B | -910.07M | -860.85M | -799.73M |
| Income Tax Expenses | 4.44M | 4.03M | 3.71M | 3.44M | 2.97M |
| Earnings from Continuing Operations | -1.03K | -1.01K | -913.77 | -864.29 | -802.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.03B | -1.01B | -913.77M | -864.29M | -802.69M |
| EBIT | -927.68M | -859.01M | -786.57M | -703.93M | -643.85M |
| EBITDA | -917.46M | -849.84M | -777.70M | -695.06M | -634.95M |
| EPS Basic | -5.70 | -5.95 | -5.59 | -5.56 | -5.40 |
| Normalized Basic EPS | -3.29 | -3.22 | -3.11 | -2.97 | -2.89 |
| EPS Diluted | -5.71 | -5.95 | -5.59 | -5.56 | -5.40 |
| Normalized Diluted EPS | -3.29 | -3.22 | -3.11 | -2.97 | -2.89 |
| Average Basic Shares Outstanding | 722.90M | 688.30M | 655.90M | 621.69M | 590.86M |
| Average Diluted Shares Outstanding | 722.90M | 688.30M | 655.90M | 621.69M | 590.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |